Editorial Policy and Fact Review Process
MedSwitcher is built to help patients understand GLP-1 medications, switching strategies, and cost differences. That only works if the facts are traceable, current, and corrected quickly when they drift.
Medications tracked: 9
Total structured facts: 85
Human-verified facts: 0
Pending review: 85
Last database update: 2026-04-07
- FDA prescribing information and approval materials
- Published clinical trial data
- Manufacturer pricing and savings program pages
- Major guideline and reference sources when relevant
We separate raw factual inputs from page copy whenever possible. Medication approval dates, dose ladders, side effect rates, trial outcomes, and pricing claims should map back to a source record instead of being improvised inline in marketing copy.
When a fact is based on trial data, we try to preserve the context that matters, including population, dose, duration, and analysis type. Because half the internet loves comparing mismatched studies and calling it journalism.
Pricing is treated as volatile. If a drug price changes, pricing pages and comparison pages should be updated quickly and marked with a fresh update date.
If you find a dosing error, outdated price, or misleading statement, email data@medswitcher.com. We review correction requests and update material issues as quickly as possible.
High-impact corrections should be fixed in the source database first, then propagated into pages and comparisons so the same error does not keep breeding in the dark.
MedSwitcher is an educational platform. It is not a medical provider, pharmacy, or prescribing service. We help users compare medication options and prepare for a conversation with a licensed clinician.
For legal boilerplate, see the Terms of Use. For data handling, see the Privacy Policy.